By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Allergan plc 

U.S. Administrative Headquarters
Morris Corporate Center III, 400 Interpace Parkway
Parsippany  New Jersey  07054  U.S.A.
Phone: 862-261-7000 Fax: n/a


Allergan plc (AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.

Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry.

We’re Looking for the World’s Best

At Allergan, we are committed to recruiting and retaining the industry’s best and brightest employees and are proud to offer opportunities for military veterans at all levels across our company. We offer business, scientific, technical, engineering, sales & marketing and a variety of other positions here in the U.S. and around the world.

At Allergan, you will find an entrepreneurial style work environment where employees and employee teams are encouraged to apply their unique talents to grow, contribute, innovate and excel. We welcome your ideas. We provide the support, resources and encouragement that enable you to take your career to new heights. We focus on challenging you, challenging ourselves and driving success.

Commit to your future and join us. Learn more about our exciting career opportunities at

Key Statistics

Ownership: Public

Web Site: Allergan
Symbol: AGN



Elan Pharmaceuticals 

CeNes Pharmaceuticals (U.S.) 

PanVera LLC 

Pharmagene Laboratories Limited  Phase ZERO(TM) products and services.

Acadia  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Acadia  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Acadia  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.

Company News
Allergan (AGN) Announces D&A Pharma Approval Of Supplemental New Drug Application (Snda) For AVYCAZ (Ceftazidime And Avibactam) 6/23/2016 6:12:11 AM
Bay Area's IMPAX Labs (IPXL) Plunks Down $586 Million for a Chunk of Teva (TEVA) and Allergan (AGN)’s Generics Portfolio 6/21/2016 6:19:07 AM
Allergan (AGN) Release: Data Presented at ASM Microbe Highlight In Vitro Antimicrobial Activity Of AVYCAZ (Ceftazidime And Avibactam) Against Several Species Of Enterobacteriaceae Pathogens And Pseudomonas Aeruginosa, Including Certain Resistant Strains 6/20/2016 8:23:23 AM
3 Big Pharmas Investors Should Take a Look At 6/20/2016 8:03:04 AM
Allergan (AGN) Reaches Out To Family Caregivers Of People With Alzheimer's Disease With New PSA, Website 6/15/2016 11:02:49 AM
Allergan (AGN) Announces FDA Acceptance Of The 510(K) Premarket Notification Filing For The XEN Glaucoma Treatment System 6/15/2016 10:46:58 AM
Allergan (AGN) To Present New Data From Its Anti-Infectives Portfolio At ASM Microbe 2016 In Boston 6/14/2016 11:38:16 AM
Once Floated as Allergan (AGN) Target, Revance (RVNC)'s Stock Drops as Crow’s Feet Drug Fails Trial 6/14/2016 9:15:59 AM
Allergan (AGN) Release: Study Reveals Gender Differences In Migraine Treatment 6/10/2016 9:38:07 AM
ActuallySheCan(SM) By Allergan (AGN) Launches Limited Edition #ActuallySheCan(SM) Tank Top Shirts, A Charitable Initiative Supporting Military Women 6/9/2016 11:53:56 AM